Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Randomized Controlled Study to Evaluate the Efficacy and Safety of ON101 Cream for the Treatment of Chronic Diabetic Foot Ulcers

Next Previous
Trial Profile

Randomized Controlled Study to Evaluate the Efficacy and Safety of ON101 Cream for the Treatment of Chronic Diabetic Foot Ulcers

Status: Completed
Phase of Trial: Phase III

Latest Information Update: 06 Nov 2023

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Centella asiatica extract (Primary)
  • Indications Diabetic foot ulcer
  • Focus Therapeutic Use
  • Acronyms MRCT Study
  • Sponsors Oneness Biotech

Most Recent Events

  • 06 Oct 2023 Results investigating the efficacy and safety of ON101, presented at the 59th Annual Meeting of the European Association for the Study of Diabetes
  • 26 Jun 2023 Results of an analysis assessing efficacy and safety of ON101 using data from this MRCT study and In a real-world scenario (case collation from 133 patients) in Taiwan presented at the 83rd Annual Scientific Sessions of the American Diabetes Association
  • 13 Jan 2023 According to a Oneness Biotech media release, results from this trial were published by the internationally renowned SCI journal JAMA Network OpenMeet.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top